ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Nicholas P.D. Smyth
Jorge M. Garcia
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smyth, N. P. D.
Right arrow Articles by Proctor, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smyth, N. P. D.
Right arrow Articles by Proctor, D.

Ann Thorac Surg 1979;28:14-21
© 1979 The Society of Thoracic Surgeons

Articles

Clinical Experience with the Isotopic Cardiac Pacemaker

Nicholas P.D. Smyth, M.D.*, John M. Keshishian, M.D., Jorge M. Garcia, M.D., Leo C. Kelly, C.V.T., Diane Proctor, R.N., M.S.N.

From the Departments of Surgery, Washington Hospital Center, Washington, DC, and Prince Georges General Hospital, Cheverly, MD

* Address reprint requests to Dr. Smyth, 106 Irving St, NW, Washington, DC 20010

Clinical experience with isotopic pacemakers in 59 patients is compared with that in 77 control patients having conventional chemical battery-powered pulse generators. The review covers a 5 1/2-year period. Statistical analysis of the two series is impossible because of the numerous variables such as age, type of disease, number of controls, types of test and control pulse generators, dates of insertion, and protocol regulations. However, there were pulse generator failures in the control group, but not in the test group.

Though not proven in this study, the isotopic cardiac pacer is likely to last longer than conventional chemical battery-powered units, and could provide lifetime pacing for many patients. The risk of carcinogenesis is minimal and seems negligible in older patients.

The isotopic cardiac pacer, in spite of restrictions of the Nuclear Regulatory Commission, should be considered for any patient with a life expectancy of 10 or more years. Paradoxically, it might be indicated in older rather than younger patients.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1979 by The Society of Thoracic Surgeons.